Pharmaceutical Company Error

McNeil Consumer Healthcare is recalling one product lot of Tylenol Extra Strength Caplets, 225 count bottles, distributed in the U.S. The recall stems from a small number of odor reports, including musty, moldy odor. The uncharacteristic musty, moldy odor has been linked to the presence of trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA). […]

Continue reading about Recall lot ABA619 Tylenol Extra Strength Caplets in 225 count bottles

Endo Pharmaceuticals and FDA notified pharmacists and patients of a nationwide consumer level recall of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg because some bottles may contain different strength tablets, resulting in patients taking more than the intended acetaminophen dose. Unintentional administration of tablets with increased acetaminophen content may result in liver toxicity, especially in […]

Continue reading about Endocet (Oxycodone / Acetaminophen) Tablets, ( 10mg, 325mg ) : Recall – Some Bottles Contain Different Strength Tablets

June 24, 2011 – Qualitest Pharmaceuticals today issued a voluntary nationwide retail level recall of Butalbital, Acetaminophen, and Caffeine Tablets USP, 50mg/325mg/40mg, and Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5mg/500mg. This recall was initiated because an individual bottle of Butalbital, Acetaminophen, and Caffeine Tablets USP, 50mg/325mg/40mg, 500 count was found incorrectly labeled with a Hydrocodone […]

Continue reading about U.S. Nationwide Retail Level Recall of Four Lots of Butalbital, Acetaminophen, Caffeine, Hydrocodone Bitartrate and Acetaminophen Tablets